S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis.

PLoS One · 2015 · PMC4437778 · PMID 25993652

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Interestingly, the area under the ROC (AUROC) curve of S100A9 was highly significant (0.947; 95% confidence interval, CI: 0.845–1.049).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.